• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

VI launches enterprise-wide product

Article

Other headlinesSiemens chooses new oncology OIS

VI launches enterprise-wide product
Vital Images has combined its advanced visualization applications with a system for managing volumetric image data across the medical enterprise. The new product, dubbed Vitrea Enterprise Suite, allows access to a single source of imaging data across an enterprise-wide network. The new offering addresses the challenge of managing multiple, disparate advanced visualization systems, according to the company, by allowing customers to leverage their existing infrastructure.

Siemens chooses new oncology OIS
Siemens Healthcare will phase out its current oncology information system, LANTIS, in favor of a next generation OIS offered by partner IMPAC Medical Systems. The installed base running LANTIS will have the option of upgrading to the IMPAC product MOSAIQ or continue using their current systems, according to Siemens. Consequent to the shift toward MOSAIQ, Siemens is extending customers service support and application training to include MOSAIQ. The shift toward a new OIS is part of a new agreement between the two companies that extends their alliance, forged in 1992, until 2016 and adds MOSAIQ to the Siemens oncology product portfolio. Siemens and IMPAC will also work together to develop interfaces between MOSAIQ and IONTRIS, Siemens’ robotic patient positioning and imaging system used in particle (proton and carbon ion) therapy.

Recent Videos
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.